These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 22234826)

  • 1. Suitability of isolated rat jejunum model for demonstration of complete absorption in humans for BCS-based biowaiver request.
    Peternel L; Kristan K; Petruševska M; Rižner TL; Legen I
    J Pharm Sci; 2012 Apr; 101(4):1436-49. PubMed ID: 22234826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.
    Kim JS; Mitchell S; Kijek P; Tsume Y; Hilfinger J; Amidon GL
    Mol Pharm; 2006; 3(6):686-94. PubMed ID: 17140256
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An improved prediction of the human in vivo intestinal permeability and BCS class of drugs using the in vitro permeability ratio obtained for rat intestine using an Ussing chamber system.
    Li H; Jin HE; Shim WS; Shim CK
    Drug Dev Ind Pharm; 2013 Oct; 39(10):1515-22. PubMed ID: 22934579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The utility of rat jejunal permeability for biopharmaceutics classification system.
    Zakeri-Milani P; Valizadeh H; Tajerzadeh H; Islambulchilar Z
    Drug Dev Ind Pharm; 2009 Dec; 35(12):1496-502. PubMed ID: 19929209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-situ intestinal rat perfusions for human Fabs prediction and BCS permeability class determination: Investigation of the single-pass vs. the Doluisio experimental approaches.
    Lozoya-Agullo I; Zur M; Wolk O; Beig A; González-Álvarez I; González-Álvarez M; Merino-Sanjuán M; Bermejo M; Dahan A
    Int J Pharm; 2015 Mar; 480(1-2):1-7. PubMed ID: 25595387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal permeability study of minoxidil: assessment of minoxidil as a high permeability reference drug for biopharmaceutics classification.
    Ozawa M; Tsume Y; Zur M; Dahan A; Amidon GL
    Mol Pharm; 2015 Jan; 12(1):204-11. PubMed ID: 25423288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive study on regional human intestinal permeability and prediction of fraction absorbed of drugs using the Ussing chamber technique.
    Sjöberg Å; Lutz M; Tannergren C; Wingolf C; Borde A; Ungell AL
    Eur J Pharm Sci; 2013 Jan; 48(1-2):166-80. PubMed ID: 23103351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In silico predictions of gastrointestinal drug absorption in pharmaceutical product development: application of the mechanistic absorption model GI-Sim.
    Sjögren E; Westergren J; Grant I; Hanisch G; Lindfors L; Lennernäs H; Abrahamsson B; Tannergren C
    Eur J Pharm Sci; 2013 Jul; 49(4):679-98. PubMed ID: 23727464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vitro rat intestine segmental perfusion model to investigate permeability and predict oral fraction absorbed.
    Castella ME; Reist M; Mayer JM; Turban JJ; Testa B; Boursier-Neyret C; Walther B; Delbos JM; Carrupt PA
    Pharm Res; 2006 Jul; 23(7):1543-53. PubMed ID: 16779709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstrating suitability of the Caco-2 cell model for BCS-based biowaiver according to the recent FDA and ICH harmonised guidelines.
    Jarc T; Novak M; Hevir N; Rižner TL; Kreft ME; Kristan K
    J Pharm Pharmacol; 2019 Aug; 71(8):1231-1242. PubMed ID: 31155721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do the recommended standards for in vitro biopharmaceutic classification of drug permeability meet the "passive transport" criterion for biowaivers?
    Žakelj S; Berginc K; Roškar R; Kraljič B; Kristl A
    Curr Drug Metab; 2013 Jan; 14(1):21-7. PubMed ID: 22497571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Sensitive Medium-Throughput Method to Predict Intestinal Absorption in Humans Using Rat Intestinal Tissue Segments.
    Da Silva LC; Da Silva TL; Antunes AH; Rezende KR
    J Pharm Sci; 2015 Sep; 104(9):2807-12. PubMed ID: 25690454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The complexity of intestinal permeability: Assigning the correct BCS classification through careful data interpretation.
    Zur M; Hanson AS; Dahan A
    Eur J Pharm Sci; 2014 Sep; 61():11-7. PubMed ID: 24262076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human small intestinal and colonic tissue mounted in the Ussing chamber as a tool for characterizing the intestinal absorption of drugs.
    Rozehnal V; Nakai D; Hoepner U; Fischer T; Kamiyama E; Takahashi M; Yasuda S; Mueller J
    Eur J Pharm Sci; 2012 Aug; 46(5):367-73. PubMed ID: 22418036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Caco-2 cells, biopharmaceutics classification system (BCS) and biowaiver.
    Smetanová L; Stĕtinová V; Svoboda Z; Kvetina J
    Acta Medica (Hradec Kralove); 2011; 54(1):3-8. PubMed ID: 21542416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Effect of Excipients on the Permeability of BCS Class III Compounds and Implications for Biowaivers.
    Parr A; Hidalgo IJ; Bode C; Brown W; Yazdanian M; Gonzalez MA; Sagawa K; Miller K; Jiang W; Stippler ES
    Pharm Res; 2016 Jan; 33(1):167-76. PubMed ID: 26286187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of the biopharmaceutics classification system (BCS) to oral modified release (MR) formulations; what do we need to consider?
    Wilding IR
    Eur J Pharm Sci; 1999 Jul; 8(3):157-9. PubMed ID: 10379037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the full potential of the biopharmaceutics classification system reached?
    Bergström CA; Andersson SB; Fagerberg JH; Ragnarsson G; Lindahl A
    Eur J Pharm Sci; 2014 Jun; 57():224-31. PubMed ID: 24075971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.